Treatment of complicated community-acquired infections with ertapenem, the first Group 1 carbapenem. Introduction.
Goldstein
Ellie J C
EJ
R M Alden Research Laboratory, Santa Monica, CA 90404, USA. EJCGMD@aol.com
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D015780:Carbapenems / Q000145:classification; D017714:Community-Acquired Infections / Q000188:drug therapy* / Q000382:microbiology; D024881:Drug Resistance, Bacterial; D000077727:Ertapenem; D006801:Humans; D007769:Lactams / Q000494:pharmacology / Q000627:therapeutic use*; D047090:beta-Lactams
D000900:Anti-Bacterial Agents; D015780:Carbapenems; D007769:Lactams; D047090:beta-Lactams; D000077727:Ertapenem